<html>
<head>PUBMED IDs for RNF115</head>
<body bgcolor='#C5F0F2'><h1>RNF115</h1><a href='https://pubmed.ncbi.nlm.nih.gov/20019814/'>BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.</a> April 13  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22850893/'>Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.</a> January 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24027428/'>RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.</a> April 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24403860/'>Regulation of metformin response by breast cancer associated gene 2.</a> September 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24852021/'>BCA2/Rabring7 targets HIV-1 Gag for lysosomal degradation in a tetherin-independent manner.</a> June 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25751625/'>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.</a> June 13  2015<br></body></html>
